Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Patient Navigation Programs Improve Outcomes, Net Financial Benefits
Key clinical point: Patient navigation programs net better clinical and financial outcomes across the spectrum of cancer care.
Major finding: Most studies found that programs improved measures of screening, diagnosis, and treatment; financial benefits included reduced treatment costs improved life expectancy and quality-adjusted life-years, and decreased health care use.
Study details: Systematic review of 113 articles assessing patient navigation programs, 14 of which reported on cost-effectiveness.
Disclosures: One investigator disclosed receiving grant funding from the Merck Foundation and being a stockholder in Pfizer and a member of the American Cancer Society Patient Navigation Round Table; the other investigators made no disclosures. The study was supported by the Susan G. Komen Foundation and the Bradley Charles Cooper Foundation.
Bernardo BM et al. Cancer. 2019 Apr 29. doi: 10.1002/cncr.32147.
